InflaRx NV Total Risk Alpha

IFRX Stock  USD 0.94  0.03  3.30%   
The Total Risk Alpha reading for InflaRx NV is computed from historical trading observations. Values reflect historical observations within the available dataset. Normalization methods and data feeds may affect reported values. Broader indicator relationships are reflected within Equity Screeners. InflaRx NV has a market cap of 63.68 M, operating margin of -420.15%, ROE of -72.49%. Review Risk vs Return Analysis for a broader allocation view. Portfolio composition is shown for contextual purposes. The allocation includes a position in InflaRx NV. The position falls within the allocation view. The sizing of each position reflects the overall allocation strategy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Our How to Buy InflaRx Stock guide explains the steps to invest in InflaRx NV stock.
InflaRx NV has current Total Risk Alpha of 0.4872. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.

Total Risk Alpha

 = 

RFR + (ER[b] - ER[a])

x

STD[a] / STD[b]

 = 
0.4872
ER[a] = Expected return on investing in InflaRx NV
ER[b] = Expected return on market index or selected benchmark
STD[a] =   Standard Deviation of returns on InflaRx NV
STD[b] = Standard Deviation of selected market or benchmark
RFR = Risk Free Rate of return. Typically T-Bill Rate

Total Risk Alpha Peers Comparison

Total Risk Alpha Relative To Other Indicators

InflaRx NV is rated below average in total risk alpha among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about 40.04 of Maximum Drawdown per Total Risk Alpha. At 40.04 , InflaRx NV's Maximum Drawdown-to-Total Risk Alpha multiple reflects the spread between these metrics
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund. Compare InflaRx NV to Peers

Other Technical Indicators